As of Mar 20
| +0.07 / +0.29%|
The 9 analysts offering 12-month price forecasts for Insmed Inc have a median target of 41.00, with a high estimate of 54.00 and a low estimate of 31.00. The median estimate represents a +68.17% increase from the last price of 24.38.
The current consensus among 9 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.